Module 7: (c) Special Population Considerations; Lipids Flashcards
1
Q
Resistant HTN
-Considerations
A
- Sequentially combine agents w/ different MOA
- Meds are dosed at maximally tolerated doses
- Effective diuretic use almost always necessary
2
Q
Resistant HTN
-Triple Combo option?
A
- ACEi or ARB PLUS long-acting Di-hydropyridine CCB (Amlodipine) PLUS long-acting thiazide diuretic (Consider Chlorthalidone)
3
Q
Resistant HTN
-Adding a 4th medication?
A
- If HTN is still resistant to triple combo
- Add MRA such as Spironolactone - WATCH POTASSIUM**
4
Q
Resistant HTN
-When a loop diuretic is better?
A
- Add a loop to a thiazide-diuretic for patient with PERSISTENT EDEMA
- Add Loop to thiazide or switch to loop for patients with eGFR < 30 (Watch potassium)
5
Q
HTN in Older Adults
-
A
- Individualize goals and shared decision making***
6
Q
HTN in Older Adults
-Orthostatic Hypotension consideration?
A
- Consider Orthostatic hypotension
- Potential limiting factor to the use of antihypertensive drugs in older adults
- Hip fracture is a risk
7
Q
HTN in Older Adults
-Potential A/E’s
A
- Potential of impairment of mental function, such as confusion or sleepiness
- Think about cardiovascular risk in older adults prior to lowering diastolic pressures too low.
8
Q
HTN in Older Adults
-Meds to consider?
A
- Consider starting with a low dose of:
- Thiazide-type diuretic
- Long-acting dihydropyridine CCB - In combo therapy, start with LOW DOSES
9
Q
Non-Emergent Pediatric HTN
-Meds to consider?
A
- ACEi or ARB (AVOID in pregnancy risk)
- Long acting CCB (Amlodipine)
- Thiazide diuretics are not first choice with peds
10
Q
Non-Emergent Pediatric HTN
-Drugs NOT to use in Peds
A
- Beta Blockers are NOT RECOMMENDED as initial therapy in children
- Impaired glucose tolerance
- interference in lipid metabolism
11
Q
HTN in Pregnancy
-Severe Level of BP?
A
- SBP >/= 160 mmHg and/or diastolic BP >/= 110 mmHg
- PROMPT treatment is recommended to reduce risk of maternal stroke
- SEND TO ER for IV meds
12
Q
HTN in Pregnancy
-Meds to Consider?
A
- Labetalol (alpha/beta blocker)
- Nifedipine, extended-release (Dihydropyridine CCB)
- Methyldopa (alpha agonist; milder agent; sedation)
- ALL HTN meds cross the placenta
- NO large scale study data is available
13
Q
HTN in Pregnancy
-Meds to AVOID?
A
- ACEi, ARB’s
- Direct Renin inhibitors
- Mineralocorticoid receptor antagonists (MRA’s)
- Spironolactone
- Eplerenone
14
Q
Conditions that Increase Total Cholesterol and LDL-C?
A
- Progestin
2. Protease inhibitors for treatment of HIV infection
15
Q
Conditions that Increase Triglycerides and VLDL-C?
A
- Protease inhibitors for treatment of HIV infection
- Anti-hypertensive meds (Thiazide diuretics and beta blockers)
- Corticosteroid therapy
- Oral estrogen; oral contraceptives
- Hypothyroidism and Diabetes